)
Barkha Mathur leads health coverage for the Business Standard website. She reports on the intersection of medicine, policy, and health science, with a focus on stories that impact readers’ physical and mental well-being. When not tracking the latest developments in health, she’s often reading medical research or listening to hip-hop.
Barkha Mathur leads health coverage for the Business Standard website. She reports on the intersection of medicine, policy, and health science, with a focus on stories that impact readers’ physical and mental well-being. When not tracking the latest developments in health, she’s often reading medical research or listening to hip-hop.
CBDT has released new functionality in AIS for taxpayers to display the status of the information confirmation process in real-time
NGO Population Foundation of India raises concerns over misinterpretation; advocates for contextual understanding of demographic trends
As the temperature in India soars, so does the demand for cooling essentials
TVS Motor Q4 result: The company's revenue from operations jumped to Rs 10,042 crore in Q4FY24 compared with Rs 8,031 crore in the fourth quarter of FY23
Serum Institute of India says it stopped manufacturing Covishield since December 2021
The special live trading session will have intra-day switch over from primary site to disaster recovery site
'Our US sales remain healthy driven by inhalation products, and our India formulation business is delivering ahead of market,' said Nilesh Gupta, MDirector, Lupin
DMart Q4 results: The revenue from operations of DMart rose to Rs 12,726.5 crore in Q4FY24 from Rs 10,594 crore in the same quarter of previous financial year
He was among the initial whistleblowers who raised concerns about the oversight of manufacturing defects in the 737 Max by Spirit's leadership
Fed holds rates steady, flags 'lack of further progress' on inflation
Adani portfolio of companies will continue to provide innovative, reliable, and scalable solutions to support the nation's economic growth, says Gautam Adani
AstraZeneca's acknowledgment that the vaccine may lead to thrombosis isn't a new revelation, but it underscores the need for transparent communication by the pharma companies, say experts
AstraZeneca has admitted for the first time in court documents that its Covid vaccine can cause rare side effects, marking an about-turn that may open the door for a multi-million pound legal payout
The company reports strong retail franchise with a retail book size of Rs 80,037 crore
As per CBI's charges, Khan had acquired huge proceeds of crime in cash through the illegal recruitment of staff in the Delhi Waqf Board
India, with nearly a billion eligible voters, will commence the world's largest electoral exercise on April 19
Srinivas Pallia, who was the CEO for the company's Americas 1 area, will take over as the new CEO and Managing Director from April 7
The World Economic Forum has included 90 change-makers in its Young Global Leaders Class, each below 40 years of age and hailing from a diverse range of sectors
The former MP was removed from Congress, days after criticising Maharashtra's party leadership during seat-sharing discussions with Shiv Sena (UBT) for the Lok Sabha elections
Sanjay Singh was granted bail by the Supreme Court after the ED raised no objections